Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
for
Alzheimer Disease, Agitation
Location: Port Orange FL, Tampa FL, Virginia Gardens FL, Miami FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT06937229
Phase 3, Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Port Orange FL, Edgewater FL, Winter Park FL,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Port Orange FL, Winter Park FL, New Port Richey FL,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
for
Hormone Receptor Positive Early Breast Cancer
Location: Port Orange FL, Margate FL, Beverly Hills CA
Sponsor: Rovi Pharmaceuticals Laboratories
Sex: Female
Age: 18 - 70+
Code: NCT07401381
Phase 1, Recruiting
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for
Uncontrolled Hypertension
Location: Port Orange FL, Maitland FL, Orlando FL, Leesburg FL,
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All
Age: 18 - 70+
Code: NCT07142356
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Port Orange FL, Orlando FL, Fleming Island FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase 2, Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
for
Liver Fibrosis, Hepatic Cirrhosis
Location: Port Orange FL, Jupiter FL, Miami FL, Morehead City NC,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07610837
Phase 2, Recruiting
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
for
Cardiovascular, Metabolic Disease, Dyslipidemias,
Location: Port Orange FL, Orlando FL, Jacksonville FL, Hialeah FL,
Sponsor: CRISPR Therapeutics AG
Sex: All
Age: 18 - 70+
Code: NCT07491172
Phase 1, Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
for
Healthy Participants, Dyslipidemia
Location: Port Orange FL, Jacksonville FL, Inverness FL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06980428
Phase 1, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
for
Alzheimer Disease
Location: Port Orange FL, Orlando FL, Merritt Island FL,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011732
Phase 3, Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
for
Chronic Kidney Disease and Hypertension
Location: Port Orange FL, Edgewater FL, Ocoee FL, Melbourne FL,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06742723
Phase 3, Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Location: Port Orange FL, Maitland FL, Winter Park FL, Orlando FL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06632444
Phase 3, Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Port Orange FL, Orlando FL, Lakeland FL, Tampa FL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819891
Phase 3, Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for
HIV Infections
Location: DeLand FL, Orlando FL, Tampa FL, Ft. Pierce FL,